Overweight and obese women have an increased risk for poor birth outcomes compared with normal-weight women.
Guselkumab is an investigational human monoclonal antibody directed specifically against IL-23.
Prevalence higher and glycemic control poorer in non-Hispanic blacks and Mexican-Americans, but lower percentage of type 2 diabetes cases left undiagnosed overall.
Merck's Grastek becomes the second sublingual treatment for grass pollen-induced allergic rhinitis with or without conjunctivitis.
The drug is indicated for improving glycemic control along with diet and exercise.